ReviewMolecular cancer therapeutics2018
Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer.
Bayley A Jones et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this papercites it